ALPHAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Alphazine patents expire, and what generic alternatives are available?
Alphazine is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in ALPHAZINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Alphazine
A generic version of ALPHAZINE was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
Summary for ALPHAZINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Patent Applications: | 1,999 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ALPHAZINE at DailyMed |
US Patents and Regulatory Information for ALPHAZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | ALPHAZINE | phendimetrazine tartrate | TABLET;ORAL | 085034-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |